Order Article Reprints

Seidita A, Buscemi C, Di Liberto D, Pistone M, Maestri S, Cavallo G, Cosenza S, Spagnuolo G, Giuliano A, Carlisi D, et al. Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice? International Journal of Molecular Sciences. 2025; 26(24):11782. https://doi.org/10.3390/ijms262411782

Seidita, Aurelio, Carola Buscemi, Diana Di Liberto, Mirco Pistone, Salvatore Maestri, Giorgia Cavallo, Salvatore Cosenza, Gabriele Spagnuolo, Alessandra Giuliano, Daniela Carlisi, and et al. 2025. "Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice?" International Journal of Molecular Sciences 26, no. 24: 11782. https://doi.org/10.3390/ijms262411782

Seidita, A., Buscemi, C., Di Liberto, D., Pistone, M., Maestri, S., Cavallo, G., Cosenza, S., Spagnuolo, G., Giuliano, A., Carlisi, D., Pratelli, G., Mandreucci, F., & Carroccio, A. (2025). Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an Opportunity to Improve Real Clinical Practice? International Journal of Molecular Sciences, 26(24), 11782. https://doi.org/10.3390/ijms262411782